We focus on several cancer types—including colon, head and neck, esophageal, glioblastoma, and breast cancers—where we aim to deliver precise diagnoses and personalized treatment recommendations. By integrating diverse data sources, such as histopathological imaging, genomics, and clinical information, we enable early, accurate diagnosis and tailored treatments, bringing us closer to making precision medicine a reality for cancer patients and improving both survival rates and quality of life.